Algernon Pharmaceuticals Inc.
AGN
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.65% | 13.70% | 367.95% | 378.14% | 39.80% |
| Total Receivables | 62.69% | -41.05% | -9.43% | -83.66% | -87.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 90.20% | 117.09% | 58.78% | 7.18% | -16.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.24% | 13.22% | 238.80% | 118.13% | 16.55% |
|
|
|||||
| Total Current Assets | -66.24% | 13.22% | 238.80% | 118.13% | 16.55% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.53% | -20.82% | -18.44% | -16.06% | -40.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.95% | -6.13% | -3.30% | -49.88% | -88.73% |
| Total Assets | 24.35% | -19.65% | -10.40% | -5.66% | -36.81% |
|
|
|||||
| Total Accounts Payable | 16.55% | -44.33% | -37.85% | -34.97% | -27.29% |
| Total Accrued Expenses | -29.67% | -77.29% | -62.59% | 40.50% | 3,060.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 47.64% | -47.52% | -38.46% | -34.51% | -20.34% |
|
|
|||||
| Total Current Liabilities | 47.64% | -47.52% | -38.46% | -34.51% | -20.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.25% | -47.52% | -38.46% | -34.51% | -20.34% |
|
|
|||||
| Common Stock & APIC | 2.69% | -4.51% | 1.71% | 5.32% | 3.59% |
| Retained Earnings | 0.78% | 11.80% | 3.79% | -0.20% | -7.57% |
| Treasury Stock & Other | -38.56% | -48.46% | -22.72% | -17.89% | -16.45% |
| Total Common Equity | -11.96% | 204.47% | 71.02% | 47.59% | -47.49% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.96% | 204.47% | 71.02% | 47.59% | -47.49% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.96% | 204.47% | 71.02% | 47.59% | -47.49% |
|
|
|||||